Brain Mri Articles & Analysis
14 news found
Ward Detwiler, our President & CEO, had the opportunity to speak about how STAGE is innovating the world of MR at MedTech Strategist Innovation 2021. ...
In the future, we hope this type of biomarker response will help predict a therapeutic benefit long before clinical benefits can be measured.” Oxford Brain Diagnostics Ltd is rethinking how brain health is assessed and managed. Founded in neuropathological and neuroimaging expertise, the company’s patented Cortical Disarray Measurement (CDM®) ...
The primary efficacy endpoint was the composite of symptomatic ischemic stroke and covert brain infarcts detected by MRI and the primary safety endpoint was ISTH major bleeding and clinically relevant non-major bleeding. 1808 patients participated in the trial at 196 sites and 23 different countries. ...
ByBayer AG
Importantly, patients receiving Lomecel-B were not reported to develop a serious side-effect called amyloid-related imaging abnormalities (ARIA) as assessed by magnetic resonance imaging (MRI). Other classes of Alzheimer’s drugs being tested have been reported to cause ARIA. ...
Additionally, the Phase 2a trial is designed to measure brain anatomy using MRI, and include detailed assessments of the inflammatory and vascular systems thought to contribute to the worsening of AD. The study, which will be conducted at a minimum of 6 centers, is led by Mark L. Brody, MD, of Brain Matters Research, Delray Beach, Florida. ...
Hyperfine’s Swoop® Portable MR Imaging SystemTM is designed to address the limitations of current imaging technologies and make MRI for brain imaging accessible anytime, anywhere, to any patient. ...
She is the Co-Director of the UCLA Brain Tumor Center, and Principal Investigator and Director of the NCI-designated UCLA Brain Tumor SPORE (Specialized Program of Research Excellence). ...
Brain imaging by MRI is available for patients with dementia and the prodromal stages using standard health insurance. ...
“Our safety results give us confidence that we could achieve acute pulmonary vein isolation without off-target ablation injury and with the technological elimination of gas emboli, we have not observed a single brain lesion on MRI. We are excited to continue into the next stage of clinical and regulatory development to bring this technology to physicians ...
Dr Steven Chance, CEO, Oxford Brain Diagnostics said ‘we are very excited to be working with our partners and the NIHR on this project. ...
The CDM Software Device, used as an adjunct to other diagnostic evaluations, is intended to predict conversion from MCI to Alzheimer’s disease in patients previously diagnosed with MCI. CDM technology uses noninvasive MRI brain scan data linked to changes in the brain at a cellular level, offering sensitive and accurate assessment of the ...
Guilarte, PhD, senior author of the new study, believed the answer was in the direct inhibitory effect of lead on the N-methyl-D-aspartate receptor (NMDAR), a synaptic connection point important to brain development, learning, and memory. His research in rodents found that exposure to lead blunted the function of the NMDAR. ...
The changes in brain structure are consistent with cognitive deficits found in children exposed to this chemical. ...
They will jointly conduct research to understand design and application issues involved in the use of a dedicated MRI brain scanner to image for a range of neurological and psychiatric disorders such as stroke, Alzheimer’s Disease, Parkinson’s Disease, traumatic brain disorder (TBI), depression, and autism. ...
ByGE Power